• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of cell surface targets through meta-analysis of microarray data.通过对基因芯片数据的荟萃分析鉴定细胞表面靶标。
Neoplasia. 2012 Jul;14(7):666-9. doi: 10.1593/neo.12634.
2
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.基因组和蛋白质表达谱分析确定细胞周期蛋白依赖性激酶6(CDK6)为髓母细胞瘤新的独立预后标志物。
J Clin Oncol. 2005 Dec 1;23(34):8853-62. doi: 10.1200/JCO.2005.02.8589.
3
Multiplex meta-analysis of medulloblastoma expression studies with external controls.髓母细胞瘤表达研究与外部对照的多重荟萃分析。
Pac Symp Biocomput. 2014:99-109.
4
Identification of Hub Genes in Pediatric Medulloblastoma by Multiple-Microarray Analysis.多基因芯片分析鉴定小儿髓母细胞瘤的枢纽基因。
J Mol Neurosci. 2020 Apr;70(4):522-531. doi: 10.1007/s12031-019-01451-4. Epub 2019 Dec 9.
5
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.环状RNA分析可区分髓母细胞瘤亚型,并显示WNT型髓母细胞瘤中RMST异常过表达。
Acta Neuropathol. 2021 Jun;141(6):975-978. doi: 10.1007/s00401-021-02306-2. Epub 2021 Apr 17.
6
A molecular fingerprint for medulloblastoma.髓母细胞瘤的分子指纹图谱。
Cancer Res. 2003 Sep 1;63(17):5428-37.
7
Bioinformatics Analysis of Key Genes and Pathways for Medulloblastoma as a Therapeutic Target.髓母细胞瘤关键基因和通路作为治疗靶点的生物信息学分析
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):221-227. doi: 10.31557/APJCP.2019.20.1.221.
8
Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.I型胶原蛋白在髓母细胞瘤中作为肿瘤微环境的一个组成部分过度表达。
J Neurooncol. 2008 Jan;86(2):133-41. doi: 10.1007/s11060-007-9457-5. Epub 2007 Jul 25.
9
Overexpressed TP73 induces apoptosis in medulloblastoma.过表达的TP73在髓母细胞瘤中诱导细胞凋亡。
BMC Cancer. 2007 Jul 12;7:127. doi: 10.1186/1471-2407-7-127.
10
Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.
Cancer Res. 2004 May 1;64(9):3103-11. doi: 10.1158/0008-5472.can-03-3968.

引用本文的文献

1
Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.髓母细胞瘤中Wnt枢纽基因表达的临床预后意义
Cell Mol Neurobiol. 2023 Mar;43(2):813-826. doi: 10.1007/s10571-022-01217-4. Epub 2022 Apr 2.
2
A review of computational drug repurposing.计算性药物重新利用综述。
Transl Clin Pharmacol. 2019 Jun;27(2):59-63. doi: 10.12793/tcp.2019.27.2.59. Epub 2019 Jun 28.
3
Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data.在对公共癌症基因组序列数据的二次数据分析中,区分潜在的细菌-肿瘤关联与污染。
Microbiome. 2017 Jan 25;5(1):9. doi: 10.1186/s40168-016-0224-8.
4
Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.微阵列基因表达数据联合分析在乳腺癌患者生存预测和风险评估中的比较研究。
Brief Bioinform. 2016 Sep;17(5):771-85. doi: 10.1093/bib/bbv092. Epub 2015 Oct 26.
5
Eph receptors as therapeutic targets in glioblastoma.作为胶质母细胞瘤治疗靶点的Eph受体
Br J Cancer. 2014 Sep 23;111(7):1255-61. doi: 10.1038/bjc.2014.73. Epub 2014 Aug 21.
6
Cancer subclonal genetic architecture as a key to personalized medicine.癌症亚克隆遗传结构是个性化医疗的关键。
Neoplasia. 2013 Dec;15(12):1410-20. doi: 10.1593/neo.131972.
7
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.迈向更好的药物重新定位:将现有方法进行优先级排序并整合到高效流程中。
Drug Discov Today. 2014 May;19(5):637-44. doi: 10.1016/j.drudis.2013.11.005. Epub 2013 Nov 14.
8
Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.通过改进生物标志物整合克服多基因癌症耐药性的肿瘤内异质性。
Neoplasia. 2012 Dec;14(12):1278-89. doi: 10.1593/neo.122096.

本文引用的文献

1
A brain tumor stem cell origin for glioblastoma endothelium.胶质母细胞瘤内皮细胞起源于脑肿瘤干细胞。
World Neurosurg. 2011 May-Jun;75(5-6):574-5. doi: 10.1016/j.wneu.2011.03.030.
2
Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans.术中共聚焦显微镜在脑肿瘤中的应用:人体可行性分析。
Neurosurgery. 2011 Jun;68(2 Suppl Operative):282-90; discussion 290. doi: 10.1227/NEU.0b013e318212464e.
3
Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.成人髓母细胞瘤临床结局的重新评估,重点关注复发模式。
Br J Neurosurg. 2010 Aug;24(4):460-7. doi: 10.3109/02688691003739881.
4
Micromirror-scanned dual-axis confocal microscope utilizing a gradient-index relay lens for image guidance during brain surgery.微镜扫描双轴共聚焦显微镜,利用梯度折射率中继透镜在脑外科手术中进行图像引导。
J Biomed Opt. 2010 Mar-Apr;15(2):026029. doi: 10.1117/1.3386055.
5
Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics.免疫组织化学检测表皮生长因子受体(EGFR)、原纤蛋白-2、P-钙黏蛋白和AP2β作为横纹肌肉瘤诊断生物标志物。
Histopathology. 2009 Jun;54(7):873-9. doi: 10.1111/j.1365-2559.2009.03303.x. Epub 2009 May 11.
6
Survival and late effects on development of patients with infantile brain tumor.婴儿脑肿瘤患者的生存情况及对发育的晚期影响。
Pediatr Int. 2009 Jun;51(3):337-41. doi: 10.1111/j.1442-200X.2008.02760.x. Epub 2008 Dec 29.
7
Combination of intraoperative 5-aminolevulinic acid-induced fluorescence and 3-D MR imaging for guidance of robotic laser ablation for precision neurosurgery.术中5-氨基乙酰丙酸诱导荧光与三维磁共振成像相结合用于机器人激光消融精准神经外科手术的引导
Med Image Comput Comput Assist Interv. 2008;11(Pt 2):373-80. doi: 10.1007/978-3-540-85990-1_45.
8
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.整合基因组学鉴定出具有不同基因特征、信号通路特征及临床病理特征的五种髓母细胞瘤亚型。
PLoS One. 2008 Aug 28;3(8):e3088. doi: 10.1371/journal.pone.0003088.
9
Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation.荧光素钠引导下的多形性胶质母细胞瘤手术:一项前瞻性评估。
Br J Neurosurg. 2008 Feb;22(1):99-103. doi: 10.1080/02688690701765524.
10
AILUN: reannotating gene expression data automatically.AILUN:自动重新注释基因表达数据。
Nat Methods. 2007 Nov;4(11):879. doi: 10.1038/nmeth1107-879.

通过对基因芯片数据的荟萃分析鉴定细胞表面靶标。

Identification of cell surface targets through meta-analysis of microarray data.

机构信息

Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.

出版信息

Neoplasia. 2012 Jul;14(7):666-9. doi: 10.1593/neo.12634.

DOI:10.1593/neo.12634
PMID:22904683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3421962/
Abstract

High-resolution image guidance for resection of residual tumor cells would enable more precise and complete excision for more effective treatment of cancers, such as medulloblastoma, the most common pediatric brain cancer. Numerous studies have shown that brain tumor patient outcomes correlate with the precision of resection. To enable guided resection with molecular specificity and cellular resolution, molecular probes that effectively delineate brain tumor boundaries are essential. Therefore, we developed a bioinformatics approach to analyze micro-array datasets for the identification of transcripts that encode candidate cell surface biomarkers that are highly enriched in medulloblastoma. The results identified 380 genes with greater than a two-fold increase in the expression in the medulloblastoma compared with that in the normal cerebellum. To enrich for targets with accessibility for extracellular molecular probes, we further refined this list by filtering it with gene ontology to identify genes with protein localization on, or within, the plasma membrane. To validate this meta-analysis, the top 10 candidates were evaluated with immunohistochemistry. We identified two targets, fibrillin 2 and EphA3, which specifically stain medulloblastoma. These results demonstrate a novel bioinformatics approach that successfully identified cell surface and extracellular candidate markers enriched in medulloblastoma versus adjacent cerebellum. These two proteins are high-value targets for the development of tumor-specific probes in medulloblastoma. This bioinformatics method has broad utility for the identification of accessible molecular targets in a variety of cancers and will enable probe development for guided resection.

摘要

高分辨率图像引导切除残余肿瘤细胞将使肿瘤切除更加精确和完整,从而更有效地治疗癌症,如髓母细胞瘤,这是最常见的小儿脑癌。许多研究表明,脑肿瘤患者的预后与切除的精确性相关。为了实现具有分子特异性和细胞分辨率的引导切除,有效描绘脑肿瘤边界的分子探针是必不可少的。因此,我们开发了一种生物信息学方法来分析微阵列数据集,以鉴定编码候选细胞表面生物标志物的转录本,这些标志物在髓母细胞瘤中高度富集。结果确定了 380 个基因,这些基因在髓母细胞瘤中的表达比正常小脑组织中的表达高出两倍以上。为了富集可用于细胞外分子探针的靶标,我们进一步通过基因本体论对该列表进行过滤,以鉴定定位于质膜上或质膜内的蛋白质定位基因。为了验证这种荟萃分析,我们用免疫组织化学法评估了前 10 个候选物。我们鉴定了两种靶标,原纤维蛋白 2 和 EphA3,它们特异性地染色髓母细胞瘤。这些结果表明,一种新的生物信息学方法成功地鉴定了细胞表面和细胞外候选标志物,这些标志物在髓母细胞瘤与相邻小脑组织中富集。这两种蛋白是髓母细胞瘤中肿瘤特异性探针开发的高价值靶标。这种生物信息学方法具有广泛的用途,可以识别各种癌症中可及的分子靶标,并将为引导切除的探针开发提供支持。